211
Participants
Start Date
June 30, 2011
Primary Completion Date
March 29, 2015
Study Completion Date
March 29, 2015
Levocetirizine 0.5 Mg/mL Oral Solution
Subjects in two arms, will be enrolled in a classical, randomized, double blind, crossover, placebo controlled trial of Levocetirizine(LCT) with determination of the PD response to LCT as determined by suppression of histamine microvasculature response via HILD.
Children's Mercy Hospital and Clinics, Kansas City
Children's Mercy Hospital Kansas City
OTHER